利福平可按固定剂量给药替代按体重分段给药
该研究利用已发表的人群药代动力学模型,模拟利福平按体重分段给药(10–40 mg/kg)与固定剂量给药(600–2400 mg)后的暴露情况,比较第7天和第14天的中位AUC0-24h及变异性。结果显示,除最低剂量组外,两种给药方案各剂量组中位AUC0-24h差异较小(<20%);按体重分段给药仅使患者间变异性略有降低,不具临床相关性。
要点
- 除最低剂量组外,固定剂量与按体重分段给药的中位AUC0-24h差异<20%。
- 按体重分段给药仅轻微降低患者间AUC0-24h变异性,无临床相关性。
- 10 mg/kg(固定剂量600 mg)时,固定剂量给药的中位AUC0-24h高于按体重分段给药。
核心结论
- 按体重分段给药仅带来小幅且无临床相关性的AUC0-24h变异性降低,利福平可考虑固定剂量给药。
研究设计与样本
- 利用已发表的人群药代动力学模型进行模拟,比较体重分段给药(10–40 mg/kg)与固定剂量给药(600–2400 mg)的利福平暴露。
主要发现
- 除最低剂量组外,固定剂量与按体重分段给药各剂量组中位AUC0-24h差异<20%。
- 10 mg/kg(固定剂量600 mg)时,固定剂量给药的中位AUC0-24h高于按体重分段给药。
- 按体重分段给药较固定剂量给药仅轻微降低患者间变异性。
关键数值与推荐
- 体重分段给药剂量范围10–40 mg/kg,固定剂量给药范围600–2400 mg。
- 比较第7天和第14天的中位AUC0-24h及变异性。
临床怎么用
- 临床可考虑以固定剂量替代按体重分段给药利福平,但最低剂量情形需注意暴露差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The weight-band dosing in tuberculosis treatment regimen has been implemented in clinical practice for decades. Patients will receive different number of fixed dose combination tablets according to their weight-band. However, some analysis has shown that weight was not the best covariate to explain variability of rifampicin exposure. Furthermore, the rationale for using weight-band dosing instead of flat-dosing becomes questionable. Therefore, this study aimed to compare the average and the variability of rifampicin exposure after weight-band dosing and flat-dosing. METHODS: Rifampicin exposure were simulated using previously published population pharmacokinetics model at dose 10-40 mg/kg for weight-band dosing and dose 600-2400 mg for flat-dosing. The median area under the curve (AUC0-24 h) after day 7 and 14 were compared as well as the variability of each dose group between weight-band and flat-dosing. RESULTS: The difference of median AUC0-24 h of all dose groups between flat-dosing and weight-band dosing were considered low (< 20%) except for the lowest dose. At the dose of 10 mg/kg (600 mg for flat-dosing), flat-dosing resulted in higher median AUC0-24h compared to the weight-band dosing. A marginal decrease in between-patient variability was predicted for weight-band dosing compared to flat-dosing. CONCLUSIONS: Weight-band dosing yields a small and non-clinically relevant decrease in variability of AUC0-24h.
引用
- Susanto BO, Svensson RJ, Svensson EM, et al. Rifampicin Can Be Given as Flat-Dosing Instead of Weight-Band Dosing. Clin Infect Dis. 2020. PMID: 31867594. doi:10.1093/cid/ciz1202
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。